Licensed Subcutaneous Infusion Therapies in Advanced Parkinson’s Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis经批准的皮下输注疗法在晚期帕金森病中的应用：一项间接治疗比较和成本最小化分析Neurology and TherapyIF4.82025-07-080OA
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selectionBMC MEDICAL RESEARCH METHODOLOGYIF3.42020-05-0613OAAI
ESTIMATED COST SAVINGS FROM DOSE BANDING GUIDANCE: A CASE STUDY USING TREATMENTS FOR STAGE IV MELANOMAVALUE IN HEALTHIF62018-10-010OAAI
MODELLING OVERALL SURVIVAL IN IMMUNOTHERAPY USING PARAMETRIC TECHNIQUES: AVELUMAB IN PREVIOUSLY TREATED METASTATIC MERKEL CELL CARCINOMAVALUE IN HEALTHIF62018-10-010OAAI
COST EFFECTIVENESS OF NIVOLUMAB FOR PATIENTS WITH ADVANCED, PREVIOUSLY TREATED RENAL CELL CARCINOMA IN SCOTLANDVALUE IN HEALTHIF62017-10-011OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向